Life expectancy 20 years after cisplatin-based treatment for testicular cancer (TC).

被引：2
|
作者：
Lubberts, Sjoukje
Kruyt, Lara M.
Steggink, Lars Christiaan
Steursma, Gerrie
Nuver, Janine
Oosting, Sjoukje
van Ginkel, Robert J.
de Jong, Igle J.
Eulenburg, Christine
Lefrandt, Joop D.
Meijer, Coby
Sluiter, Wim J.
Gietema, Jourik A.
机构：
[1] Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Div Surg Oncol, Dept Surg, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Urol, Groningen, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
[5] Univ Med Ctr Groningen, Div Vasc Med, Dept Internal Med, Groningen, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.4550
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4550
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy
    Stelwagen, Johannes
    Lubberts, Sjoukje
    Steggink, Lars C.
    Steursma, Gerrie
    Kruyt, Lara M.
    Donkerbroek, Jan Willem
    van Roon, Arie M.
    van Gessel, Anne I.
    van de Zande, Saskia C.
    Meijer, Coby
    Grafin zu Eulenburg, Christine H.
    Oosting, Sjoukje F.
    Nuver, Janine
    Walenkamp, Annemiek M. E.
    Jan de Jong, Igle
    Lefrandt, Joop D.
    Gietema, Jourik A.
    BRITISH JOURNAL OF CANCER, 2020, 123 (11) : 1599 - 1607
  • [2] Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy
    Johannes Stelwagen
    Sjoukje Lubberts
    Lars C. Steggink
    Gerrie Steursma
    Lara M. Kruyt
    Jan Willem Donkerbroek
    Arie M. van Roon
    Anne I. van Gessel
    Saskia C. van de Zande
    Coby Meijer
    Christine H. Gräfin zu Eulenburg
    Sjoukje F. Oosting
    Janine Nuver
    Annemiek M. E. Walenkamp
    Igle Jan de Jong
    Joop D. Lefrandt
    Jourik A. Gietema
    British Journal of Cancer, 2020, 123 : 1599 - 1607
  • [3] Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer
    Stouten-Kemperman, Myrle M.
    de Ruiter, Michiel B.
    Boogerd, Willem
    Kerst, J. Martijn
    Kirschbaum, Clemens
    Reneman, Liesbeth
    Schagen, Sanne B.
    BRAIN CONNECTIVITY, 2018, 8 (07) : 398 - 406
  • [4] Re: Vascular Aging in Long-Term Survivors of Testicular Cancer More than 20 Years after Treatment with Cisplatin-Based Chemotherapy
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2022, 207 (02): : 470 - 470
  • [5] Association of GSTP1, COMT, and TPMT with testicular cancer (TC) treatment outcome after cisplatin-based chemotherapy (CBCT).
    Fung, Chunkit
    Vaughn, David J.
    Mitra, Nandita
    Ciosek, Stephanie L.
    Vardhanabhuti, Saran
    Nathanson, Katherine L.
    Kanetsky, Peter A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [6] RETINAL TOXICITY AFTER CISPLATIN-BASED CHEMOTHERAPY IN PATIENTS WITH TESTICULAR CANCER
    Gild, Philipp
    Vetterlein, Malte W.
    Dieckmann, Klaus-Peter
    Matthies, Cord
    Wagner, Walter
    Ludwig, Tim A.
    Meyer, Christian P.
    Soave, Armin
    Dulz, Simon
    Asselborn, Niels H.
    Oechsle, Karin
    Bokemeyer, Carsten
    Becker, Andreas
    Fisch, Margit
    Hartmann, Michael
    Chun, Felix K. H.
    Kluth, Luis A.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1085 - E1085
  • [7] ACUTE CEREBROVASCULAR EVENT AFTER CISPLATIN-BASED CHEMOTHERAPY FOR TESTICULAR CANCER
    GERL, A
    CLEMM, C
    WILMANNS, W
    LANCET, 1991, 338 (8763): : 385 - 386
  • [8] REAL WORLD EVIDENCE OF THE RISK OF A SECOND CANCER AMONG TESTICULAR CANCER PATIENTS AFTER CISPLATIN-BASED TREATMENT
    Luciano, S.
    Fazio-Eynullayeva, E.
    Kuranz, S.
    Stetson, B.
    VALUE IN HEALTH, 2020, 23 : S55 - S55
  • [9] Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer
    Altena, R.
    Hummel, Y. M.
    Nuver, J.
    Smit, A. J.
    Lefrandt, J. D.
    de Boer, R. A.
    Voors, A. A.
    van den Berg, M. P.
    de Vries, E. G. E.
    Boezen, H. M.
    Gietema, J. A.
    ANNALS OF ONCOLOGY, 2011, 22 (10) : 2286 - 2293
  • [10] Cisplatin-based chemotherapy of testicular cancer - Two decades after a major breakthrough
    Gerl, A
    ONKOLOGIE, 2000, 23 (02): : 106 - 111
12345